Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Auna (AUNA) Q3 2026 Earnings Call Transcript

Colombian oncology costs weighed on profits, but cash flow surged.

Auna (AUNA) reported a 10% top-line growth on an FX-neutral basis in the third quarter of 2026, with Mexico experiencing a first quarter of adjusted EBITDA growth. The company also achieved a 95% year-to-date increase in free cash flow. Mexico's Monterrey healthcare network reached its first quarter of adjusted EBITDA growth in 2026.

The company decided to terminate an unprofitable oncology risk-sharing contract in Colombia, which accounted for 4% of segment revenue. Profitability in Colombia was affected by high medical costs and drug pricing caps, while Peru's segment continued to show strong growth potential. The company maintained its full-year revenue guidance of 10% to 14% growth and revised Adjusted EBITDA expectations to remain stable or slightly decreased for the year.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fool.com →

More in Finance & Markets

More from Wednesday 18 November →